Medtronic (MDT) Capital Expenditures (2014 - 2026)

Medtronic has disclosed Capital Expenditures across 13 years of filings, most recently posting $444.0 million for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $444.0 million, down 6.72% year-over-year; the trailing twelve-month figure through Jan 2026 was $1.9 billion (up 2.68% YoY), and the FY2025 annual result was $1.9 billion, up 17.14% from the prior year.
• Capital Expenditures came in at $444.0 million for Q1 2026 at Medtronic, down from $468.0 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $520.0 million in Q3 2024 to a low of $323.0 million in Q4 2022.
• The 5-year median for Capital Expenditures is $426.0 million (2022), against an average of $414.1 million.
• Across the five-year window, Capital Expenditures dropped 16.9% in 2023 and surged 46.89% in 2024, its largest moves.
• Medtronic's Capital Expenditures stood at $323.0 million in 2022, then jumped by 42.72% to $461.0 million in 2023, then declined by 12.36% to $404.0 million in 2024, then gained by 15.84% to $468.0 million in 2025, then decreased by 5.13% to $444.0 million in 2026.
• The last three Capital Expenditures figures came in at $444.0 million (Q1 2026), $468.0 million (Q4 2025), and $504.0 million (Q3 2025), per Business Quant data.